{"id":451,"date":"2023-04-04T09:29:34","date_gmt":"2023-04-04T09:29:34","guid":{"rendered":"https:\/\/www.cic.vc\/?p=451"},"modified":"2024-04-16T12:12:45","modified_gmt":"2024-04-16T12:12:45","slug":"cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding","status":"publish","type":"post","link":"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/","title":{"rendered":"Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding"},"content":{"rendered":"<p><span class=\"text-small\">Mosaic Therapeutics is an oncology therapeutics company dedicated to resolving cancer\u2019s complexity to power new treatments for patients. The investment will be used to further advance Mosaic\u2019s pipeline of targeted oncology therapies for biomarker-stratified populations, progressing its lead programmes through preclinical development to IND-enabling studies. The funds will also support recruitment efforts, building the Company\u2019s senior leadership, experimental biology, and computational teams. The investment in this round was raised by Cambridge Innovation Capital and Syncona Investment Management, Ltd.<\/span><\/p>\n<p><span class=\"text-small\">Mosaic\u2019s use of advanced computational methods, while combining mining of large datasets with experimental approaches to identify and develop novel targeted therapies, completely reinvents the traditional approach to target and drug discovery. The Company\u2019s bespoke relationship with the Wellcome Sanger Institute provides it unique access to deep scientific expertise, infrastructure, and biological assets.<\/span><\/p>\n<p><span class=\"text-small\">Mosaic\u2019s proprietary platform applies research from co-founder Dr Mathew Garnett\u2019s Translational Cancer Genomics Laboratory at the Wellcome Sanger Institute. Dr Garnett is a Senior Group Leader at Sanger with over 20 years\u2019 experience in genomics and cancer therapeutics, with past achievements including co-discovery of BRAF mutations in cancer and Werner Syndrome helicase as a target in MSI tumours.<\/span><\/p>\n<p><strong><span class=\"text-small\">Brian Gladsden, CEO, Mosaic Therapeutics, commented:<\/span><\/strong><\/p>\n<p>&#8220;I believe that Mosaic is ideally positioned to resolve the complexity of cancer, to discover and develop targeted therapies that address areas of high unmet need. The people, platform, connection to a world-leading genomics research institute, and strong investor partnerships are truly best in class. To receive funding from such high calibre investors is testament to the potential of Mosaic\u2019s technology and multidisciplinary team, as well as the exceptional support provided by the Wellcome Sanger Institute.&#8221;<\/p>\n<p><strong>Anne Horgan, Partner at Cambridge Innovation Capital and Director of Mosaic, said:<\/strong><\/p>\n<p>&#8220;We are delighted to invest in Mosaic Therapeutics and its outstanding founders, backing our third spin out from the Wellcome Sanger Institute. We also welcome Brian, a seasoned oncology executive, to the team. Mosaic\u2019s unique combination of advanced data science, large dataset mining and experimental approaches has the capability to identify and develop novel targeted therapies for the patient groups most likely to respond to these treatments. Cambridge (UK) is a globally important hub for biotechnology and life sciences, and Mosaic is a great example of innovation in the ecosystem.&#8221;<\/p>\n<p>Mosaic is the most recent spin-out company from the Wellcome Sanger Institute, a world leader in genome research, with notable achievements including being the single largest contributor to the Human Genome Project, co-founding the International Cancer Genome Consortium, and identifying specific BRAF mutations that underpinned a new class of transformational targeted cancer therapeutics.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Mosaic Therapeutics is an oncology therapeutics company dedicated to resolving cancer\u2019s complexity to power new treatments for patients. The investment will be used to further advance Mosaic\u2019s pipeline of targeted oncology therapies for biomarker-stratified populations, progressing its lead programmes through preclinical development to IND-enabling studies. The funds will also support recruitment efforts, building the Company\u2019s [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":1360,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[5,29],"tags":[49],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding - Cambridge Innovation Capital<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding - Cambridge Innovation Capital\" \/>\n<meta property=\"og:description\" content=\"Mosaic Therapeutics is an oncology therapeutics company dedicated to resolving cancer\u2019s complexity to power new treatments for patients. The investment will be used to further advance Mosaic\u2019s pipeline of targeted oncology therapies for biomarker-stratified populations, progressing its lead programmes through preclinical development to IND-enabling studies. The funds will also support recruitment efforts, building the Company\u2019s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Cambridge Innovation Capital\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-04T09:29:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-16T12:12:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cic.vc\/wp-content\/uploads\/2023\/04\/Mosaic-Tx-background-logo-banner-v2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Colin Berwick\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cic_vc\" \/>\n<meta name=\"twitter:site\" content=\"@cic_vc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Colin Berwick\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/\",\"url\":\"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/\",\"name\":\"Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding - Cambridge Innovation Capital\",\"isPartOf\":{\"@id\":\"https:\/\/www.cic.vc\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cic.vc\/wp-content\/uploads\/2023\/04\/Mosaic-Tx-background-logo-banner-v2.png\",\"datePublished\":\"2023-04-04T09:29:34+00:00\",\"dateModified\":\"2024-04-16T12:12:45+00:00\",\"author\":{\"@id\":\"https:\/\/www.cic.vc\/#\/schema\/person\/2a0fb039a2a216c26fcd56ba96b54734\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/#primaryimage\",\"url\":\"https:\/\/www.cic.vc\/wp-content\/uploads\/2023\/04\/Mosaic-Tx-background-logo-banner-v2.png\",\"contentUrl\":\"https:\/\/www.cic.vc\/wp-content\/uploads\/2023\/04\/Mosaic-Tx-background-logo-banner-v2.png\",\"width\":1600,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cic.vc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cic.vc\/#website\",\"url\":\"https:\/\/www.cic.vc\/\",\"name\":\"Cambridge Innovation Capital\",\"description\":\"We enable visionaries to build global, category-leading companies.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cic.vc\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cic.vc\/#\/schema\/person\/2a0fb039a2a216c26fcd56ba96b54734\",\"name\":\"Colin Berwick\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.cic.vc\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e7f6d32e9af553e4e969350cc5adddbb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e7f6d32e9af553e4e969350cc5adddbb?s=96&d=mm&r=g\",\"caption\":\"Colin Berwick\"},\"url\":\"https:\/\/www.cic.vc\/author\/colin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding - Cambridge Innovation Capital","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/","og_locale":"en_GB","og_type":"article","og_title":"Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding - Cambridge Innovation Capital","og_description":"Mosaic Therapeutics is an oncology therapeutics company dedicated to resolving cancer\u2019s complexity to power new treatments for patients. The investment will be used to further advance Mosaic\u2019s pipeline of targeted oncology therapies for biomarker-stratified populations, progressing its lead programmes through preclinical development to IND-enabling studies. The funds will also support recruitment efforts, building the Company\u2019s [&hellip;]","og_url":"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/","og_site_name":"Cambridge Innovation Capital","article_published_time":"2023-04-04T09:29:34+00:00","article_modified_time":"2024-04-16T12:12:45+00:00","og_image":[{"width":1600,"height":1200,"url":"https:\/\/www.cic.vc\/wp-content\/uploads\/2023\/04\/Mosaic-Tx-background-logo-banner-v2.png","type":"image\/png"}],"author":"Colin Berwick","twitter_card":"summary_large_image","twitter_creator":"@cic_vc","twitter_site":"@cic_vc","twitter_misc":{"Written by":"Colin Berwick","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/","url":"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/","name":"Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding - Cambridge Innovation Capital","isPartOf":{"@id":"https:\/\/www.cic.vc\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/#primaryimage"},"image":{"@id":"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cic.vc\/wp-content\/uploads\/2023\/04\/Mosaic-Tx-background-logo-banner-v2.png","datePublished":"2023-04-04T09:29:34+00:00","dateModified":"2024-04-16T12:12:45+00:00","author":{"@id":"https:\/\/www.cic.vc\/#\/schema\/person\/2a0fb039a2a216c26fcd56ba96b54734"},"breadcrumb":{"@id":"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/#primaryimage","url":"https:\/\/www.cic.vc\/wp-content\/uploads\/2023\/04\/Mosaic-Tx-background-logo-banner-v2.png","contentUrl":"https:\/\/www.cic.vc\/wp-content\/uploads\/2023\/04\/Mosaic-Tx-background-logo-banner-v2.png","width":1600,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/www.cic.vc\/cambridge-innovation-capital-invests-in-mosaic-therapeutics-28m-series-a-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cic.vc\/"},{"@type":"ListItem","position":2,"name":"Cambridge Innovation Capital invests in Mosaic Therapeutics $28m Series A Funding"}]},{"@type":"WebSite","@id":"https:\/\/www.cic.vc\/#website","url":"https:\/\/www.cic.vc\/","name":"Cambridge Innovation Capital","description":"We enable visionaries to build global, category-leading companies.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cic.vc\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.cic.vc\/#\/schema\/person\/2a0fb039a2a216c26fcd56ba96b54734","name":"Colin Berwick","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.cic.vc\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e7f6d32e9af553e4e969350cc5adddbb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e7f6d32e9af553e4e969350cc5adddbb?s=96&d=mm&r=g","caption":"Colin Berwick"},"url":"https:\/\/www.cic.vc\/author\/colin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/posts\/451"}],"collection":[{"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/comments?post=451"}],"version-history":[{"count":3,"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/posts\/451\/revisions"}],"predecessor-version":[{"id":3001,"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/posts\/451\/revisions\/3001"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/media\/1360"}],"wp:attachment":[{"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/media?parent=451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/categories?post=451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cic.vc\/wp-json\/wp\/v2\/tags?post=451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}